X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21101) 21101
Book Review (5497) 5497
Publication (925) 925
Newsletter (201) 201
Magazine Article (130) 130
Book Chapter (76) 76
Conference Proceeding (44) 44
Book / eBook (31) 31
Newspaper Article (11) 11
Reference (10) 10
Dissertation (6) 6
Transcript (6) 6
Trade Publication Article (3) 3
Paper (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19050) 19050
index medicus (18563) 18563
antihypertensive agents - therapeutic use (12298) 12298
hypertension - drug therapy (10686) 10686
male (10393) 10393
female (10060) 10060
antihypertensive agents - adverse effects (8349) 8349
middle aged (8107) 8107
hypertension (7864) 7864
aged (6976) 6976
adult (5433) 5433
blood pressure - drug effects (4899) 4899
antihypertensive agents - administration & dosage (4037) 4037
treatment outcome (3777) 3777
hypertension - physiopathology (3492) 3492
risk factors (3335) 3335
blood pressure (3235) 3235
pharmacology & pharmacy (2973) 2973
abridged index medicus (2867) 2867
peripheral vascular disease (2693) 2693
drug therapy, combination (2642) 2642
hypertension - complications (2422) 2422
blood-pressure (2417) 2417
antihypertensive agents - pharmacology (2333) 2333
drug therapy (2307) 2307
antihypertensive drugs (2274) 2274
medicine, general & internal (2067) 2067
animals (1962) 1962
aged, 80 and over (1954) 1954
double-blind method (1897) 1897
cardiac & cardiovascular systems (1888) 1888
angiotensin-converting enzyme inhibitors - therapeutic use (1604) 1604
medicine & public health (1598) 1598
time factors (1574) 1574
mortality (1543) 1543
prospective studies (1532) 1532
care and treatment (1443) 1443
therapy (1298) 1298
risk (1296) 1296
research (1293) 1293
calcium channel blockers - therapeutic use (1217) 1217
internal medicine (1215) 1215
hypertension - diagnosis (1193) 1193
diuretics (1136) 1136
clinical trials as topic (1124) 1124
dose-response relationship, drug (1121) 1121
ophthalmology (1117) 1117
management (1109) 1109
follow-up studies (1088) 1088
health aspects (1077) 1077
adolescent (1072) 1072
analysis (1040) 1040
hypertension - epidemiology (1037) 1037
adrenergic beta-antagonists - therapeutic use (1016) 1016
randomized controlled trials as topic (999) 999
retrospective studies (997) 997
prevention (989) 989
prevalence (968) 968
angiotensin-converting enzyme inhibitors - adverse effects (935) 935
double-blind (930) 930
diuretics - therapeutic use (922) 922
diabetes (893) 893
dosage and administration (893) 893
drug combinations (893) 893
antihypertensive agents (879) 879
intraocular pressure - drug effects (878) 878
hypertension - etiology (869) 869
cardiology (857) 857
disease (856) 856
rats (855) 855
tetrazoles - therapeutic use (838) 838
cardiovascular disease (837) 837
heart rate - drug effects (835) 835
drugs (810) 810
blood pressure - physiology (807) 807
trial (796) 796
angiotensin (790) 790
hypertension, pulmonary - drug therapy (788) 788
efficacy (776) 776
glaucoma (772) 772
calcium channel blockers - adverse effects (770) 770
pregnancy (760) 760
clinical trials (747) 747
drug interactions (727) 727
urology & nephrology (725) 725
cardiovascular diseases - prevention & control (722) 722
stroke (709) 709
antihypertensive agents - pharmacokinetics (702) 702
age factors (690) 690
risk assessment (689) 689
patient compliance (663) 663
amlodipine (661) 661
hypertension - therapy (661) 661
tetrazoles - adverse effects (660) 660
angiotensin ii type 1 receptor blockers - therapeutic use (652) 652
valsartan (640) 640
antihypertensive therapy (639) 639
renin-angiotensin system - drug effects (637) 637
safety (636) 636
young adult (633) 633
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19342) 19342
German (704) 704
French (375) 375
Spanish (203) 203
Russian (193) 193
Japanese (186) 186
Italian (96) 96
Swedish (55) 55
Norwegian (46) 46
Danish (43) 43
Chinese (42) 42
Polish (42) 42
Dutch (39) 39
Czech (34) 34
Hungarian (31) 31
Portuguese (29) 29
Romanian (21) 21
Finnish (16) 16
Bulgarian (11) 11
Hebrew (11) 11
Croatian (8) 8
Serbian (5) 5
Slovak (5) 5
Ukrainian (5) 5
Turkish (4) 4
Korean (3) 3
Lithuanian (2) 2
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Clinical trials | Family medical history | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Fatal | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Index Medicus | Abridged Index Medicus | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 03/2015, Volume 101, Issue 3, pp. 538 - 548
Background: Recent evidence has indicated that flavanol consumption may have many health benefits in humans, including improved cognitive activities.... 
Lipid peroxidation | Insulin resistance | Cocoa flavanols | Blood pressure | Cognitive function | cognitive function | blood pressure | PROANTHOCYANIDINS | cocoa flavanols | PERFORMANCE | CHOCOLATE | FLAVAN-3-OLS | RICH COCOA | lipid peroxidation | IMPAIRMENT | CARDIOVASCULAR HEALTH | NUTRITION & DIETETICS | MOOD | INSULIN-RESISTANCE | insulin resistance | BRAIN | Beverages - adverse effects | Flavonols - adverse effects | Follow-Up Studies | Humans | Antihypertensive Agents - administration & dosage | Flavonols - therapeutic use | Hypertension - drug therapy | Male | Cognition | Cognitive Dysfunction - prevention & control | Cacao - adverse effects | Aged, 80 and over | Aging | Female | Flavonols - administration & dosage | Hypertension - diet therapy | Double-Blind Method | Dairy Products - adverse effects | Cognitive Dysfunction - metabolism | Insulin Resistance | Nootropic Agents - therapeutic use | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Cacao - chemistry | Nootropic Agents - adverse effects | Antihypertensive Agents - adverse effects | Hypertension - metabolism | Antioxidants - therapeutic use | Nootropic Agents - administration & dosage | Antioxidants - administration & dosage | Antioxidants - adverse effects | Aged | Lipid Peroxidation | Cohort Studies | Analysis | Beverages | Cocoa | Medical research | Flavonoids | Flavones | Bioflavonoids | Nutritional aspects | Medicine, Experimental | Research | Health aspects | Diet | Vitamin B | Older people | Cognitive ability | Clinical trials | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 420 - 428
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 10/2008, Volume 149, Issue 8, pp. 521 - 530
Background: Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension.... 
INHALED ILOPROST | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ORAL SILDENAFIL | EFFICACY | TREPROSTINIL | SAFETY | COMBINATION THERAPY | PROSTACYCLIN | BOSENTAN | Piperazines - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Sulfones - adverse effects | Antihypertensive Agents - administration & dosage | Hypertension, Pulmonary - physiopathology | Male | Dyspepsia - chemically induced | Purines - administration & dosage | Hemodynamics - physiology | Walking - physiology | Sildenafil Citrate | Time Factors | Epoprostenol - adverse effects | Adult | Female | Hypertension, Pulmonary - drug therapy | Purines - adverse effects | Drug Therapy, Combination | Headache - chemically induced | Double-Blind Method | Administration, Oral | Piperazines - adverse effects | Antihypertensive Agents - adverse effects | Adolescent | Quality of Life | Aged | Vasodilator Agents - adverse effects | Hypertension, Pulmonary - etiology | Vasodilator Agents - administration & dosage | Epoprostenol - administration & dosage | Sulfones - administration & dosage | Complications and side effects | Epoprostenol | Dosage and administration | Sildenafil | Drug therapy, Combination | Research | Drug therapy | Pulmonary hypertension | Hypertension | Inhibitor drugs | Patients | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 18, pp. 1887 - 1898
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9721, pp. 1173 - 1181
Summary Background The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that... 
Internal Medicine | KIDNEY-DISEASE | AMLODIPINE | BENAZEPRIL | MEDICINE, GENERAL & INTERNAL | CONVERTING-ENZYME-INHIBITOR | ALBUMINURIA | NITRIC-OXIDE | INSUFFICIENCY | DIABETIC-NEPHROPATHY | BLOOD-PRESSURE | PROGRESSION | Blood Pressure | Calcium Channel Blockers - adverse effects | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Kidney Failure, Chronic - urine | Male | Albuminuria | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Amlodipine - administration & dosage | Hydrochlorothiazide - adverse effects | Kidney Failure, Chronic - physiopathology | Diuretics - administration & dosage | Glomerular Filtration Rate | Double-Blind Method | Risk Factors | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Disease Progression | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Calcium Channel Blockers - administration & dosage | Kidney Failure, Chronic - complications | Creatinine - blood | Hypertension - complications | Aged | Benzazepines - administration & dosage | Diuretics - adverse effects | Drug Combinations | Hypertension | Chronic kidney failure | Patient outcomes | Development and progression | Drug therapy, Combination | Drug therapy | Methods | Risk factors | Studies | Heart failure | Blister packs | Mortality | Kidney diseases | Diabetes | Index Medicus | Abridged Index Medicus | Drugs | blood pressure | Side effects | Filtration | secondary analysis | Dialysis | clinical trials | hypertension | Kidney
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9767, pp. 741 - 750
Summary Background Raised blood pressure is common in acute stroke, and is associated with an increased risk of poor outcomes. We aimed to examine whether... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | DESIGN | MANAGEMENT | ACUTE ISCHEMIC STROKE | INTRAVENOUS NIMODIPINE | GUIDELINES | CEREBRAL-HEMORRHAGE TRIAL | OUTCOMES | BLOOD-PRESSURE REDUCTION | HYPERTENSION | INTERVENTION | Meta-Analysis as Topic | Angiotensin II Type 1 Receptor Blockers - adverse effects | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Stroke - physiopathology | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Treatment Failure | Aged, 80 and over | Female | Blood Pressure - drug effects | Benzimidazoles - adverse effects | Odds Ratio | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Brain Ischemia - complications | Double-Blind Method | Drug Administration Schedule | Europe | Stroke - drug therapy | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Regression Analysis | Stroke - etiology | Aged | Tetrazoles - adverse effects | Cerebral Hemorrhage - complications | Hypertension | Stroke (Disease) | Complications and side effects | Candesartan | Research | Drug therapy | Health aspects | Studies | Stroke | Blood pressure | Clinical medicine | Index Medicus | Abridged Index Medicus | blood pressure | Hospitals | stroke | Mortality | myocardial infarction | composite materials | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article